Results 161 to 170 of about 3,463,529 (362)

Chemical Technology Division, Unit Operations Section Monthly Progress Report for October 1959 [PDF]

, 1960
J C Bresee, J.O. Blomeke, P A Haas, R W Horton, A.D. Ryon, C.D. Watson, M E Whatley   +6 more
openalex   +1 more source

Inorganic arrangement crystal beryllium, lithium, selenium and silicon

, 2015
The use of inorganic crystals technology has been widely date. Since quartz crystals for watches in the nineteenth century, and common way radio in the early twentieth century, to computer chips with new semiconductor materials. Chemical elements such as
Fedrigo, Desire Francine Gobato, Gobato, Alekssander, Gobato, Ricardo   +2 more
core  

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Power Reactor Fuel Reprocessing Status Report of ORNL Chemical Technology Division for April 1959

, 1959
J. O. Blomeke, H. E. Goeller, W. H. Lewis   +2 more
openalex   +2 more sources

CHEMICAL TECHNOLOGY DIVISION, UNIT OPERATIONS SECTION MONTHLY PROGRESS REPORT, JUNE 1961 [PDF]

, 1962
M.E. Whatley, P.A. Haas, R.W. Horton, A.D. Ryon, J.C. Suddath, C.D. Watson   +5 more
openalex   +1 more source

Determinants of international activity: evidence from the chemical processing industry. [PDF]

This paper empirically investigates two important determinants of international activity through wholly owned operations, joint-ventures and technology licensing, namely country risk and intellectual property rights (IPRs) protection.
Fosfuri, Andrea
core  

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

CHEMICAL TECHNOLOGY DIVISION, UNIT OPERATIONS SECTION MONTHLY PROGRESS REPORT FOR DECEMBER 1956

, 1957
J.C. Bresee, J.T. Long, E.O. Nurmi, C.D. Watson   +3 more
openalex   +2 more sources

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Editorial: Innovators in chemistry: 2022

Frontiers in Chemistry
Aleksandar Kondinski, Aleksandar Kondinski   +1 more
doaj   +1 more source